前往化源商城

American Journal of Veterinary Research 2012-09-01

Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs.

Kathryn K Surdyk, Dawn L Sloan, Scott A Brown

文献索引:Am. J. Vet. Res. 73(9) , 1485-90, (2012)

全文:HTML全文

摘要

To determine the effects of carprofen and etodolac on renal function in euvolemic dogs and dogs with extracellular fluid volume depletion induced via administration of furosemide.12 female Beagles.Dogs received a placebo, furosemide, carprofen, etodolac, furosemide and carprofen, and furosemide and etodolac. The order in which dogs received treatments was determined via a randomization procedure. Values of urine specific gravity, various plasma biochemical variables, glomerular filtration rate (GFR [urinary clearance of creatinine]), and renal plasma flow (urinary clearance of para-aminohippuric acid) were determined before and after 8 days of drug administration. A washout time of approximately 12 days was allowed between treatment periods.Administration of furosemide, furosemide and carprofen, and furosemide and etodolac caused changes in urine specific gravity and values of plasma biochemical variables. Administration of carprofen or etodolac alone did not have a significant effect on renal plasma flow or GFR. Concurrent administration of furosemide and carprofen or furosemide and etodolac caused a significant decrease in GFR. After 12-day washout periods, mean values of GFR were similar to values before drug administration for all treatments.Results indicated GFR decreased after 8 days of concurrent administration of furosemide and carprofen or furosemide and etodolac to dogs. Administration of preferential cyclooxygenase-2 inhibitors to dogs with extracellular fluid volume depletion or to dogs treated with diuretics may transiently impair renal function.

相关化合物

结构式 名称/CAS号 全部文献
4-氨基马尿酸 结构式 4-氨基马尿酸
CAS:61-78-9
依托度酸 结构式 依托度酸
CAS:41340-25-4
卡洛芬 结构式 卡洛芬
CAS:53716-49-7